The Enterprise Value as of November 2024 (TTM) for Eagle Pharmaceuticals, Inc. (EGRX) is 24.78M

According to Eagle Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 24.78M. This represents a change of -93.47% compared to the average of 379.29M of the last 4 quarters.

Eagle Pharmaceuticals, Inc. (EGRX) Historical Enterprise Value (quarterly & annually)

How has EGRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Eagle Pharmaceuticals, Inc. over the last ten years is 615.65M. The current 24.78M Enterprise Value has changed 302.47% with respect to the historical average. Over the past ten years (40 quarters), EGRX's Enterprise Value was at its highest in in the December 2015 quarter at 1.30B. The Enterprise Value was at its lowest in in the March 2014 quarter at 58.11M.

Eagle Pharmaceuticals, Inc. (EGRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eagle Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eagle Pharmaceuticals, Inc. (EGRX) Average Enterprise Value

How has EGRX Enterprise Value performed in the past?

The current Enterprise Value of Eagle Pharmaceuticals, Inc. (EGRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Eagle Pharmaceuticals, Inc. (EGRX) Enterprise Value vs. Peers

How is EGRX’s Enterprise Value compared to its peers?

Eagle Pharmaceuticals, Inc.’s Enterprise Value is less than ANI Pharmaceuticals, Inc. (1.68B), less than Phibro Animal Health Corporation (1.20B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (5.20B), less than Collegium Pharmaceutical, Inc. (1.80B), less than Silver Spike Investment Corp. (33.56M), less than Regencell Bioscience Holdings Limited (73.51M), less than Amphastar Pharmaceuticals, Inc. (2.62B), less than Alkermes plc (4.63B), less than Evolus, Inc. (721.48M), less than Procaps Group, S.A. (325.69M), less than Delta 9 Cannabis Inc. (65.31M), less than RAMM Pharma Corp. (0), greater than City View Green Holdings Inc. (6.65M), less than Craftport Cannabis Corp. (9.03B), greater than Speakeasy Cannabis Club Ltd. (2.88M),

Build a custom stock screener for Eagle Pharmaceuticals, Inc. (EGRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eagle Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eagle Pharmaceuticals, Inc. (EGRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eagle Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.